Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ETON
DateTimeSourceHeadlineSymbolCompany
20/12/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
20/12/202411:50GlobeNewswire Inc.Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)NASDAQ:ETONEton Pharmaceuticals Inc
17/12/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
17/12/202411:50GlobeNewswire Inc.Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical TrialNASDAQ:ETONEton Pharmaceuticals Inc
12/12/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
12/12/202421:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ETONEton Pharmaceuticals Inc
09/12/202422:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
03/12/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
03/12/202411:50GlobeNewswire Inc.Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial OfficerNASDAQ:ETONEton Pharmaceuticals Inc
25/11/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
25/11/202411:50GlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)NASDAQ:ETONEton Pharmaceuticals Inc
12/11/202421:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
12/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
12/11/202421:01GlobeNewswire Inc.Eton Pharmaceuticals Reports Third Quarter 2024 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
07/11/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
07/11/202412:00GlobeNewswire Inc.Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
06/11/202421:30GlobeNewswire Inc.Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024NASDAQ:ETONEton Pharmaceuticals Inc
04/10/202420:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
03/10/202410:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
03/10/202410:30GlobeNewswire Inc.Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from IpsenNASDAQ:ETONEton Pharmaceuticals Inc
22/08/202420:30GlobeNewswire Inc.Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
08/08/202420:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
08/08/202420:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
08/08/202420:01GlobeNewswire Inc.Eton Pharmaceuticals Reports Second Quarter 2024 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
02/08/202420:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ETONEton Pharmaceuticals Inc
30/07/202421:30GlobeNewswire Inc.Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024NASDAQ:ETONEton Pharmaceuticals Inc
15/07/202420:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
15/07/202420:05GlobeNewswire Inc.Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
11/06/202420:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
09/05/202420:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ETON